Open access
126
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
Michael Bogart1 US Value Evidence & Outcomes, R&D US, GSK, Research Triangle Park, NC, USAView further author information
, Lindsay GS Bengtson2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAView further author information
, Mary G Johnson2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAhttps://orcid.org/0000-0002-1115-0472View further author information
, Scott H Bunner2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAhttps://orcid.org/0000-0003-3280-5164View further author information
, Noelle N Gronroos2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAView further author information
& Kristi K DiRocco3 USA, Medical Affairs, GSK, Collegeville, PA, USACorrespondence[email protected]
https://orcid.org/0009-0006-2988-5684View further author information
https://orcid.org/0009-0006-2988-5684View further author information
Pages 97-110
|
Received 20 Jul 2023, Accepted 15 Dec 2023, Published online: 15 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.